deltatrials
Completed OBSERVATIONAL NCT01640600

Yale Pink and Blue Kids: Effects of Exposure During Pregnancy to Nicotine or Antidepressants in 4-8 Year Old Children (PABKids)

Yale Pink and Blue Kids: Effects of in Utero Exposure to Nicotine and Selective Serotonin Reuptake Inhibitors in 4-8 Year Old Children

Sponsor: National Alliance for Research on Schizophrenia and Depression

Updated 10 times since 2017 Last updated: Jun 2, 2017 Started: Oct 31, 2011 Primary completion: Jul 31, 2013 Completion: Jul 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01640600, this observational or N/A phase trial focuses on Behavioral Problems and Cognitive Problems and remains completed. Sponsored by National Alliance for Research on Schizophrenia and Depression, it has been updated 10 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshotCompleted~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshotCompleted~Apr 2018 – ~May 2018 · 30 days · monthly snapshotCompleted~May 2018 – ~Jun 2018 · 31 days · monthly snapshotCompleted~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshotCompleted~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

10 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Dec 2021 — Jul 2024 [monthly]

    Completed

  4. Jan 2021 — Dec 2021 [monthly]

    Completed

  5. Nov 2020 — Jan 2021 [monthly]

    Completed

Show 5 earlier versions
  1. Jun 2018 — Nov 2020 [monthly]

    Completed

  2. May 2018 — Jun 2018 [monthly]

    Completed

  3. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NANone

  4. Aug 2017 — Apr 2018 [monthly]

    Completed NA

  5. Jan 2017 — Aug 2017 [monthly]

    Completed NA

    First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Alliance for Research on Schizophrenia and Depression
  • National Institute on Drug Abuse (NIDA)
  • Yale University
Data source: Yale University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations